Jia Yinan, Li Na, Zhang Xinxin, Lu Zhiwei, You Xiaonan, Xu Qiaoling
Yinan Jia, Department of Internal Medical-Cardiovascular, Baoding NO.1 Central Hospital, Baoding, Hebei 071000, China.
Na Li, Department of Infectious Diseases, Baoding NO.1 Central Hospital, Baoding, Hebei 071000, China.
Pak J Med Sci. 2024 Aug;40(7):1533-1538. doi: 10.12669/pjms.40.7.7873.
To evaluate the clinical efficacy, safety and compliance of quality nursing intervention in the treatment of chronic heart failure combined with respiratory tract infections.
This was a retrospective study. One hundred and twenty patients with chronic heart failure combined with respiratory tract infections were recruited at Baoding No.1 Central Hospital from June 2021 to March 2023 and randomly divided into the control group (n=60) and the experimental group (n=60). Patients in the control group were given regular specialist care on the basis of basic treatment, while those in the experimental group were given a quality care intervention model. The differences in clinical efficacy, improvement time of symptoms after treatment, etc. between the two groups were compared and analyzed.
The response rate of the experimental group was 88%, which was significantly higher than that of the control group (73%), with a statistically significant difference (P=0.04). The time of fever reduction, cough subsidence and lung rales disappearance in the experimental group were significantly shorter than those of the control group, with statistically significant differences (P<0.05). The incidence of nursing related adverse events in the experimental group was 8%, which was lower than that of 23% in the control group, with a statistically significant difference(P=0.03).
Quality nursing intervention is an effective treatment for patients with chronic heart failure combined with respiratory infections, boasting a variety of benefits such as reduced nursing risk, improved quality of nursing, and increased patient compliance and satisfaction. It contributes to rapid symptom improvement and significant clinical efficacy.
评估优质护理干预在治疗慢性心力衰竭合并呼吸道感染中的临床疗效、安全性及依从性。
本研究为回顾性研究。选取2021年6月至2023年3月在保定市第一中心医院就诊的120例慢性心力衰竭合并呼吸道感染患者，随机分为对照组（n = 60）和试验组（n = 60）。对照组患者在基础治疗的基础上给予常规专科护理，试验组患者给予优质护理干预模式。比较分析两组患者的临床疗效、治疗后症状改善时间等差异。
试验组有效率为88%，显著高于对照组的73%，差异有统计学意义（P = 0.04）。试验组患者退热、咳嗽缓解及肺部啰音消失时间均显著短于对照组，差异有统计学意义（P < 0.05）。试验组护理相关不良事件发生率为8%，低于对照组的23%，差异有统计学意义（P = 0.03）。
优质护理干预是治疗慢性心力衰竭合并呼吸道感染患者的有效方法，具有降低护理风险、提高护理质量、增加患者依从性和满意度等多种益处，有助于症状快速改善及显著的临床疗效。
